AZTR

Insider Trades

Name	Value	Action	Price	Current Price
Salva Francisco D.Director, Officer: President And CEO $500k4.1M shares BuyMar 18, 2026 $0.123 --
Salva Francisco D.Director, Officer: President And CEO $62500 shares BuyMar 18, 2026 $0.123 --

News

prnewswire.comAzitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyondprnewswire.comJun 17

prnewswire.comAzitra, Inc. to Present at 2026 BIO International Conventionprnewswire.comJun 16

prnewswire.comAzitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meetingprnewswire.comJun 4

prnewswire.comAzitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meetingprnewswire.comMay 27

prnewswire.comAzitra, Inc. Announces Q1 2026 Results and Provides Business Updatesprnewswire.comMay 13

Trade AZTR

About Azitra, Inc.

Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton syndrome, a specific skin disorder. ATR-04: Another modified S. epidermidis strain, designed to alleviate the papulopustular rash commonly experienced by cancer patients undergoing epidermal growth factor receptor inhibitor therapy. ATR-01: An engineered recombinant human filaggrin protein developed for the treatment of ichthyosis vulgaris, another dermatological ailment. Founded in 2014, Azitra, Inc. operates from its headquarters in Branford, Connecticut.

CEO: Francisco D. Salva
IPO Date: Jun 20, 2023

Market Data

Open: $0.217
High: $0.248
Low: $0.1717
Volume: 111.9M
Avg Volume: 17.5M
52W High: $1.83
52W Low: $0.10

Valuation

Market Cap: $1.8M
Enterprise Value: $-7.9M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-11M
Revenue: $0
Net Income: $-11M
Cash: $2.1M
Debt: $422k

Events

EarningsAug 10

EPS est. -0.115